Avalyn, in pursuit of better lung drugs, banks $300M in an IPO - BioPharma Dive
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO BioPharma Dive
ORIGINAL SOURCE →via IPO News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] (LEAD) LG Energy Solution swings to Q1 loss amid EV market slowdown
- [FINANCE] Microsoft beats expectations but its guidance comes up light, disappointing investors
- [FINANCE] Yale Neuroscientist Explains Why Crypto Bear Market is Different Now - BeInCrypto
- [FINANCE] Privacy in the AI era is possible, says Proton's CEO, but one thing keeps him up at night
- [FINANCE] Seoul addresses concerns over planned review of USMCA to Mexico
- [FINANCE] Oborevwori credits Tinubu reforms, proposes national dialogue